መነሻ › አኩት ማይሎይድ ሊውኬሚያ › ከንታኪ › Louisville
በLouisville፣ KY ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 12 ጥናቶች በLouisville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UofL Health Brown Cancer Center, Louisville
- Norton Cancer Institute, Louisville
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Norton Children's Hospital, Louisville
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Norton Children's Hospital, Louisville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Norton Children's Hospital, Louisville
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Norton Children's Hospital, Louisville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of Louisville Hospital - James Brown Cancer Center, Louisville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Kentucky Markey Cancer Center, Louisville
- Norton Cancer Institute - St. Matthews, Louisville
በሌሎች ከተሞች ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ጥናቶች
- Houston, TX85 ጥናቶች
- New York City, NY51 ጥናቶች
- Boston, MA44 ጥናቶች
- Seattle, WA41 ጥናቶች
- Baldwin Park, CA40 ጥናቶች
- Columbus, OH35 ጥናቶች
- Philadelphia, PA34 ጥናቶች
- Durham, NC33 ጥናቶች
- Atlanta, GA31 ጥናቶች
- Tampa, FL29 ጥናቶች
- Chicago, IL26 ጥናቶች
- Portland, OR25 ጥናቶች
በLouisville ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር22 ጥናቶች
- ከባድ ሰውነት17 ጥናቶች
- ከመጠን በላይ ክብደት15 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)14 ጥናቶች
- የልብ ድካም13 ጥናቶች
- Multiple Myeloma12 ጥናቶች
- የእንቁላል ካንሰር12 ጥናቶች
- የጡንቻ ካንሰር11 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ11 ጥናቶች
- የሳንባ ካንሰር11 ጥናቶች
- ሜላኖማ10 ጥናቶች
- የፕሮስቴት ካንሰር10 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።